Within a few years of using prostate-specific antigen (PSA) tests, we saw an amazing shift: By the mid-1990s, most men newly diagnosed with prostate cancer were curable. Since then, studies have shown that while PSA screening reduces a man’s likelihood of dying from prostate cancer, it does not reduce overall mortality. The problem has been with how we use PSA tests.
Contributor: Michael Kattan, PhD, Chair, Department of Quantitative Health Sciences, Cleveland Clinic Lerner Research Institute What is your risk of having colorectal cancer? If you are approaching or have passed your 50th birthday, your doctor probably has advised you to have colorectal cancer screening to determine that. And that’s the problem. Since the late 20th … Read More
Waiting to hear back from a doctor about a serious health issue can be excruciating. Even if you’re a doctor yourself.